Home / Resources

Resources

drug development red flags series part 1

When a clean PK profile is actually a warning sign

A clean pharmacokinetics profile is often seen as a green light. But in practice, overly tidy PK data can hide analytical artefacts, non-linear behaviour, or poorly understood clearance mechanisms that surface later at significant cost.

Filter

Webinar | On-demand

Recorded on: 08.07.25

From racemic to pure the art and science of enantiomer separation

From the classical and Dutch resolution methods to preferential crystallization and deracemization, learn the best ways to obtain your desired purity!

Recorded on: 02.06.21

In vivo pharmacokinetic experiments in preclinical drug development

Despite a good part of ADME research in drug discovery and preclinical development can be performed using various in silico or in vitro systems, eventually it becomes necessary to evaluate the pharmacokinetic (PK) profile in animals to elucidate in vivo DMPK properties of the drug candidates.

Recorded on: 17.12.20

Accelerating medicinal chemistry by rapid analoging

Medicinal chemistry is the art of rapidly evolving initial hits to clinical candidates via smart, information driven multiparametric optimization.

Recorded on: 30.09.20

Solid-state chemistry part II: Optimal form selection by controlled crystallization

The webinar by Dr. Edwin Aret of Symeres focuses on advanced strategies for selecting and controlling solid forms of pharmaceutical compounds through crystallization techniques.

Recorded on: 11.09.20

Route scouting for kilogram-scale manufacturing of APIs

The webinar by Dr. Martin Strack provides an in-depth exploration of the strategies and considerations involved in developing scalable synthetic routes for Active Pharmaceutical Ingredients (APIs)

Recorded on: 19.06.20

Solid-state chemistry part I: Introduction

This webinar, presented by solid-state expert Edwin Aret, offers an insightful introduction to the field of solid-state chemistry.

Speak with our discovery and development experts

See how we can support the discovery and development of your next breakthrough.